Document Detail

Novel pharmacologic therapies in development for acute decompensated heart failure.
MedLine Citation:
PMID:  23314727     Owner:  NLM     Status:  In-Data-Review    
Acute heart failure is a public health issue with morbidity and mortality exceeding that of myocardial infarction. Novel compounds for the treatment of acute heart failure are clearly needed and fall into the general categories of inotropic, vasodilatory and other compounds in phase I to III of development. Furthest along are omecamtiv mecarbil (a cardiac myosin activator), ularitide (a natriuretic and diuretic peptide) and relaxin (a vasodilator). Each compound has a unique set of assets and liabilities that will aid in the understanding of the syndrome and application to the right patients at the right time in this heterogeneous syndrome. This review will explore current and future novel pharmacologic therapies for the treatment of acute heart failure.
Justin A Ezekowitz
Related Documents :
11122437 - Sequential changes in localization of repair-related proteins (heat shock protein 70, u...
1789047 - Comparison of q with non-q myocardial infarction using signal averaged ecg.
18422517 - Vascular endothelial growth factor-165 gene therapy promotes cardiomyogenesis in reperf...
19396667 - The association between staphylococcus aureus bacteremia and acute myocardial infarction.
12022537 - Liberal use of delayed sternal closure for postcardiotomy hemodynamic instability.
1115067 - The effects of practolol on the dysrhythmias complicating acute ischemic heart disease.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current cardiology reports     Volume:  15     ISSN:  1534-3170     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  329     Citation Subset:  IM    
Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The Evolution of the Papanicolaou Smear.
Next Document:  Improving the chemical shift dispersion of multidimensional NMR spectra of intrinsically disordered ...